1651 - 1700 of 8100 Results
Title
Year
- RESTRICTEDTitle: Outcome Assessment in Parkinson Disease Prevention TrialsJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 52End Page: 60Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200236Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/52.full.pdfCitation Count: 13
- RESTRICTEDTitle: Path to Parkinson Disease PreventionJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 76End Page: 83Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200793Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/76.full.pdfCitation Count: 14
- Repeat‐Associated Non‐AUG Translation of AGAGGG Repeats that Cause X‐Linked Dystonia‐Parkinsonism2022OPENTitle: Repeat‐Associated Non‐AUG Translation of AGAGGG Repeats that Cause X‐Linked Dystonia‐ParkinsonismJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2284End Page: 2289Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29183Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29183Citation Count: 7
- RESTRICTEDTitle: Who to Enroll in Parkinson Disease Prevention Trials?Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 10End Page: 18Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200812Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/10.full.pdfCitation Count: 8
- OPENTitle: Lifestyle Interventions for the Prevention of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 42End Page: 51Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200787Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/42.full.pdfCitation Count: 32
- OPENTitle: Planning for Prevention of Parkinson DiseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 1End Page: 9Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200789Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/1.full.pdfCitation Count: 16
- OPENTitle: Vestibular Sensory Conflict During Postural Control, Freezing of Gait, and Falls in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 11Start Page: 2257End Page: 2262Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29189Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29189Citation Count: 12
- OPENTitle: What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?Journal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 7_Supplement_1Start Page: 61End Page: 67Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/wnl.0000000000200786Best OA location URL: https://n.neurology.org/content/neurology/99/7_Supplement_1/61.full.pdfCitation Count: 14
- RESTRICTEDTitle: Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson diseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.971252Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.971252/pdfCitation Count: 8
- OPENTitle: Removal of proteinase K resistant αSyn species does not correlate with cell survival in a virus vector-based Parkinson's disease mouse modelJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 218Issue #:Start Page: 109213End Page: 109213Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.neuropharm.2022.109213Best OA location URL: https://doi.org/10.1016/j.neuropharm.2022.109213Citation Count: 8
- Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body Diseases2022OPENTitle: Serum MicroRNAs Predict Isolated Rapid Eye Movement Sleep Behavior Disorder and Lewy Body DiseasesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2086End Page: 2098Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29171Best OA location URL: https://doi.org/10.1002/mds.29171Citation Count: 11
- OPENTitle: A Remote Longitudinal Observational Study of Individuals at Genetic Risk for Parkinson DiseaseJournal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 8Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000200008Best OA location URL: https://ng.neurology.org/content/nng/8/5/e200008.full.pdfCitation Count: 7
- OPENTitle: Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 146Issue #: 2Start Page: 507End Page: 518Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac294Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169283Citation Count: 11
- OPENTitle: HypermobileEhlers‐DanlosSyndrome: A Prodromal Subtype of Functional Movement Disorders?Journal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 7Start Page: 956End Page: 960Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13545Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547148Citation Count: 3
- OPENTitle: Impact of 100 LRRK2 variants linked to Parkinson's disease on kinase activity and microtubule bindingJournal Name: Biochemical JournalPublisher: Portland Press Ltd.Vol: 479Issue #: 17Start Page: 1759End Page: 1783Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1042/bcj20220161Best OA location URL: https://portlandpress.com/biochemj/article-pdf/479/17/1759/936843/bcj-2022-0161.pdfCitation Count: 82
- RESTRICTEDTitle: Longitudinal Mediating Effect of Depression on the Relationship between Excessive Daytime Sleepiness and Activities of Daily Living in Parkinson’s DiseaseJournal Name: Clinical GerontologistPublisher: Informa UK LimitedVol: 47Issue #: 3Start Page: 426End Page: 435Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1080/07317115.2022.2111014Citation Count: 6
- RESTRICTEDTitle: Management of dysphagia and gastroparesis in Parkinson’s disease in real-world clinical practice – Balancing pharmacological and non-pharmacological approachesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 14Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2022.979826Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2022.979826/pdfCitation Count: 8
- OPENTitle: Patient‐Reported Symptoms in the Global Multiple System Atrophy RegistryJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 7Start Page: 967End Page: 971Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13544Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547130Citation Count: 4
- Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last Decade2022RESTRICTEDTitle: Structural Insights and Development of LRRK2 Inhibitors for Parkinson’s Disease in the Last DecadeJournal Name: GenesPublisher: MDPI AGVol: 13Issue #: 8Start Page: 1426End Page: 1426Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/genes13081426Best OA location URL: https://www.mdpi.com/2073-4425/13/8/1426/pdf?version=1660204965Citation Count: 5
- OPENTitle: Reduced synaptic activity and dysregulated extracellular matrix pathways in midbrain neurons from Parkinson’s disease patientsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00366-zBest OA location URL: https://www.nature.com/articles/s41531-022-00366-z.pdfCitation Count: 36
- RESTRICTEDTitle: The Role of Rab Proteins in Parkinson’s Disease SynaptopathyJournal Name: BiomedicinesPublisher: MDPI AGVol: 10Issue #: 8Start Page: 1941End Page: 1941Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/biomedicines10081941Best OA location URL: https://www.mdpi.com/2227-9059/10/8/1941/pdf?version=1660634425Citation Count: 15
- OPENTitle: Gray Matter Volume Loss in Proposed Brain‐First and Body‐First Parkinson's Disease SubtypesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 10Start Page: 2066End Page: 2074Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.29172Best OA location URL: https://doi.org/10.1002/mds.29172Citation Count: 17
- RESTRICTEDTitle: Scalable approaches for functional analyses of whole-genome sequencing non-coding variantsJournal Name: Human Molecular GeneticsPublisher: Oxford University Press (OUP)Vol: 31Issue #: R1Start Page: R62End Page: R72Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1093/hmg/ddac191Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9585666Citation Count: 4
- RESTRICTEDTitle: Parkinson’s Disease and Sugar Intake—Reasons for and Consequences of a Still Unclear CravingJournal Name: NutrientsPublisher: MDPI AGVol: 14Issue #: 15Start Page: 3240End Page: 3240Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/nu14153240Best OA location URL: https://www.mdpi.com/2072-6643/14/15/3240/pdf?version=1659947851Citation Count: 12
- RESTRICTEDTitle: Views of in‐person and virtual group exercise before and during the pandemic in people with Parkinson diseaseJournal Name: PM&RPublisher: WileyVol: 15Issue #: 6Start Page: 772End Page: 779Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/pmrj.12848Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119971Citation Count: 2
- OPENTitle: Endolysosomal cholesterol export: More than just NPC1Journal Name: BioEssaysPublisher: WileyVol: 44Issue #: 10Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/bies.202200111Best OA location URL: https://doi.org/10.1002/bies.202200111Citation Count: 10
- OPENTitle: Elevation of gangliosides in four brain regions from Parkinson’s disease patients with a GBA mutationJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00363-2Best OA location URL: https://www.nature.com/articles/s41531-022-00363-2.pdfCitation Count: 14
- Adjuvant medical therapy in cervical dystonia after deep brain stimulation: A retrospective analysis2022OPENTitle: Adjuvant medical therapy in cervical dystonia after deep brain stimulation: A retrospective analysisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.927573Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.927573/pdfCitation Count: 2
- OPENTitle: Increased Phospho‐AKT in Blood Cells from LRRK2 G2019S Mutation CarriersJournal Name: Annals of NeurologyPublisher: WileyVol: 92Issue #: 5Start Page: 888End Page: 894Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/ana.26469Best OA location URL: https://diposit.ub.edu/dspace/bitstream/2445/194378/1/730022.pdfCitation Count: 0
- OPENTitle: Increasing Computational Protein Design Literacy through Cohort-Based Learning for Undergraduate StudentsJournal Name: Journal of Chemical EducationPublisher: American Chemical Society (ACS)Vol: 99Issue #: 9Start Page: 3177End Page: 3186Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acs.jchemed.2c00500Best OA location URL: https://www.biorxiv.org/content/biorxiv/early/2022/05/25/2022.05.24.493341.full.pdfCitation Count: 3
- Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's Disease2022OPENTitle: Prevalence and Incidence of Nonmotor Symptoms in Individuals with and Without Parkinson's DiseaseJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 9Issue #: 7Start Page: 961End Page: 966Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mdc3.13533Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13533Citation Count: 4
- OPENTitle: Systematic Functional Analysis of PINK1 and PRKN Coding VariantsJournal Name: CellsPublisher: MDPI AGVol: 11Issue #: 15Start Page: 2426End Page: 2426Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/cells11152426Best OA location URL: https://www.mdpi.com/2073-4409/11/15/2426/pdf?version=1659696395Citation Count: 15
- OPENTitle: The Role of Transportation in the Enrollment of Elderly African Americans into Exercise and Memory Study: GEMS StudyJournal Name: Journal of Racial and Ethnic Health DisparitiesPublisher: Springer Science and Business Media LLCVol: 10Issue #: 4Start Page: 1837End Page: 1845Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1007/s40615-022-01367-7Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40615-022-01367-7.pdfCitation Count: 3
- RESTRICTEDTitle: Epigenetic Clock Acceleration Is Linked to Age at Onset of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 9Start Page: 1831End Page: 1840Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29157Citation Count: 26
- RESTRICTEDTitle: The economic imperatives for technology enabled wellness centered healthcareJournal Name: Journal of Public Health PolicyPublisher: Springer Science and Business Media LLCVol: 43Issue #: 3Start Page: 456End Page: 468Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1057/s41271-022-00356-8Best OA location URL: https://link.springer.com/content/pdf/10.1057/s41271-022-00356-8.pdfCitation Count: 2
- OPENTitle: Clinical trajectories and biomarkers for weight variability in early Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00362-3Best OA location URL: https://www.nature.com/articles/s41531-022-00362-3.pdfCitation Count: 13
- OPENTitle: Putting participants and study partners FIRST when clinical trials end earlyJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 18Issue #: 12Start Page: 2736End Page: 2746Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/alz.12732Best OA location URL: https://escholarship.org/content/qt8jf94062/qt8jf94062.pdf?t=s0lt8rCitation Count: 8
- RESTRICTEDTitle: An overview of the active clinical trials for Parkinson’s disease psychosisJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 4Start Page: 165End Page: 170Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2022-0020Citation Count: 0
- RESTRICTEDTitle: Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysisJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 119End Page: 128Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.004Citation Count: 12
- RESTRICTEDTitle: Cellular senescence: a key therapeutic target in aging and diseasesJournal Name: Journal of Clinical InvestigationPublisher: American Society for Clinical InvestigationVol: 132Issue #: 15Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1172/jci158450Best OA location URL: http://www.jci.org/articles/view/158450/files/pdfCitation Count: 155
- RESTRICTEDTitle: Diagnosis and treatment of orthostatic hypotensionJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 21Issue #: 8Start Page: 735End Page: 746Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(22)00169-7Best OA location URL: https://pure.rug.nl/ws/files/234637992/1_s2.0_S1474442222001697_main.pdfCitation Count: 54
- RESTRICTEDTitle: Evidence for immune system alterations in peripheral biological fluids in Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 170Issue #:Start Page: 105744End Page: 105744Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2022.105744Best OA location URL: https://doi.org/10.1016/j.nbd.2022.105744Citation Count: 16
- RESTRICTEDTitle: Glutamate modulation for the treatment of levodopa induced dyskinesia: a brief review of the drugs tested in the clinicJournal Name: Neurodegenerative Disease ManagementPublisher: Informa UK LimitedVol: 12Issue #: 4Start Page: 203End Page: 214Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/nmt-2021-0055Citation Count: 7
- RESTRICTEDTitle: Isotope tracing in health and diseaseJournal Name: Current Opinion in BiotechnologyPublisher: Elsevier BVVol: 76Issue #:Start Page: 102739End Page: 102739Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.copbio.2022.102739Best OA location URL: https://doi.org/10.1016/j.copbio.2022.102739Citation Count: 13
- Late Breaking Orals2022OPENTitle: Late Breaking OralsJournal Name: Journal of Extracellular VesiclesPublisher: WileyVol: 11Issue #: S2Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/jev2.12252Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jev2.12252Citation Count: 0
- RESTRICTEDTitle: Microbes and Parkinson’s disease: from associations to mechanismsJournal Name: Trends in MicrobiologyPublisher: Elsevier BVVol: 30Issue #: 8Start Page: 749End Page: 760Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.tim.2022.01.004Best OA location URL: http://www.cell.com/article/S0966842X2200004X/pdfCitation Count: 14
- OPENTitle: Mitochondrial hyperfusion via metabolic sensing of regulatory amino acidsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 40Issue #: 7Start Page: 111198End Page: 111198Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2022.111198Best OA location URL: http://www.cell.com/article/S2211124722010154/pdfCitation Count: 19
- OPENTitle: Parkinson’s Disease Severity Estimation using Deep Learning and Cloud TechnologyJournal Name: 2022 IEEE International Conference on Omni-layer Intelligent Systems (COINS)Publisher: IEEEVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1109/coins54846.2022.9854945Best OA location URL: https://zenodo.org/record/7020693/files/PD-Severity.pdfCitation Count: 0
- OPENTitle: Peripheral tau as a biomarker for neurodegenerative diseases: is life on Earth, life on Mars?Journal Name: BrainPublisher: Oxford University Press (OUP)Vol: 145Issue #: 8Start Page: 2629End Page: 2631Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awac281Best OA location URL: https://academic.oup.com/brain/article-pdf/145/8/2629/45599741/awac281.pdfCitation Count: 0
- PLA2G6-associated neurodegeneration in four different populations-case series and literature review2022RESTRICTEDTitle: PLA2G6-associated neurodegeneration in four different populations-case series and literature reviewJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 101Issue #:Start Page: 66End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense: publisher-specific-oaDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.06.016Best OA location URL: http://manuscript.elsevier.com/S1353802022002115/pdf/S1353802022002115.pdfCitation Count: 4